| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 65.18B | $ 45.04B | $ 34.12B | $ 28.54B | $ 28.32B |
| Gross Profit | $ 54.62B | $ 36.62B | $ 27.04B | $ 21.91B | $ 21.01B |
| Operating Income | $ 29.70B | $ 17.50B | $ 10.79B | $ 8.65B | $ 7.93B |
| EBITDA | $ 27.94B | $ 15.23B | $ 8.57B | $ 8.66B | $ 8.04B |
| Net Income | $ 20.64B | $ 10.59B | $ 5.24B | $ 6.24B | $ 5.58B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.27B | $ 3.42B | $ 2.93B | $ 2.21B | $ 3.91B |
| Total Assets | $ 112.48B | $ 78.71B | $ 64.01B | $ 49.49B | $ 48.81B |
| Total Debt | $ 42.50B | $ 33.64B | $ 25.23B | $ 16.24B | $ 16.88B |
| Net Debt | $ 35.34B | $ 30.38B | $ 22.41B | $ 14.17B | $ 13.07B |
| Total Liabilities | $ 85.94B | $ 64.44B | $ 53.14B | $ 38.71B | $ 39.65B |
| Stockholders' Equity | $ 26.54B | $ 14.19B | $ 10.77B | $ 10.65B | $ 8.98B |
| Cash Flow | |||||
| Free Cash Flow | $ 8.97B | $ 414.30M | $ -3.15B | $ 4.60B | $ 5.39B |
| Operating Cash Flow | $ 16.81B | $ 8.82B | $ 4.24B | $ 7.59B | $ 7.37B |
| Investing Cash Flow | $ -10.97B | $ -9.30B | $ -7.15B | $ -3.76B | $ -2.87B |
| Financing Cash Flow | $ -2.21B | $ 1.23B | $ 3.50B | $ -5.41B | $ -4.13B |
Eli Lilly & Co (CH:LLY)
:LLY
